NAHDI MEDICAL COMPANY

Business Segments Nahdi Medical Company

Equities

4164

SA15HG521213

Drug Retailers

Market Closed - Saudi Arabian S.E. Other stock markets 12:20:00 11/03/2026 GMT			5-day change	1st Jan Change
107.00 ^SAR	+1.04%		+9.18%	+12.63%

03-09	Tadawul All Share Index Tumbles as Triple-Digit Oil Weighs	MT
03-09	Nahdi Medical's FY25 Net Profit, Revenue Rise	MT

Sales 2024 by Business Segment

© MarketScreener.com See more

Sales 2024 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (SAR)

Fiscal Period: December	2017	2018	2019	2020	2021	2022	2023	2024
Drug Stores and Pharmacies
Retailing				-	-	-	-	9.45B
Total Assets				-	-	-	-	6.17B
Interest Expense				-	-	-	-	-73.72M
Income Tax Expense				-	-	-	-	13.82M
CAPEX				-	-	-	-	-340M
EBT				-	-	-	-	835M
Gross Profit				-	-	-	-	3.53B
D&A				-	-	-	-	676M
Operating Income				-	-	-	-	873M
Net Income				-	-	-	-	821M
Group Pharmacies				6.41B	-	-	-	-
Gross Profit				2.62B	-	-	-	-
Agents				2.23B	-	-	-	-
Gross Profit				651M	-	-	-	-
Pharma				-	3.73B	4.26B	4.41B	-
Front Shop				-	4.3B	4.28B	4.13B	-
Others				-	34.13M	74.63M	172M	-

Geographical Revenue Distribution History

Geographical breakdown of sales (SAR)

Fiscal Period: December	2017	2018	2019	2020	2021	2022	2023	2024
Kingdom of Saudi Arabia				8.64B	8.07B	8.62B	8.71B	9.45B
Total Assets				4.65B	4.29B	4.94B	5.37B	6.17B
Interest Expense				-57.5M	-78.88M	-79.38M	-50.46M	-73.72M
Income Tax Expense				45.33M	44.74M	50.11M	51.63M	13.82M
D&A				493M	547M	576M	595M	676M
CAPEX				-320M	-306M	-275M	-354M	-340M
Gross Profit				3.25B	3.3B	3.52B	3.52B	3.53B
Net Income				849M	813M	888M	893M	821M
EBT				894M	857M	938M	944M	835M
Operating Income				966M	920M	1B	961M	873M

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW